4.0 Recommendations When DCC first started producing breast implants in the early 1960s, corporate culture and ethics may not have been considered as a core business objective which maybe an explanation for the issues and the litigation they faced. A company’s reputation is based on its ethical business conduct and in today’s interconnected and innovation driven economy it is increasingly imperative to understand how leaders need to think about the goals while still focusing on an ethical obligation of delivering safe products to patients. A robust code of conduct is mandatory as a basis for this. Based on the internal discrepancies it would be difficult to provide detailed justifications and practices for future projects without a revised …show more content…
Therefore the considerations described in section 3.4 are also relevant here (what ethical practices were in place at that time and how to improve). In addition the ethics of use of animals in research should be well considered to prevent any future crisis (Macklin 1999, p. 489), particularly addressing the safety and security of patients and in the context of physician and patient interactions. Appropriate steps to ensure integrity and robust ethical business conduct should be well explored while maintaining standards and fulfilling obligations to the public. 5.0 Implementation The current version of DCCs code of conduct does not represent integrity, trust, reputation, accountability, safety and security from an ethical perspective. All research involving human participants must be conducted in a manner that respects the dignity, safety and rights of research participants and that recognizes the responsibilities of researchers. An accelerated approach 6-12 month approach will be adopted to introduce the new code of conduct. 5.1 Strategy …show more content…
This will provide an opportunity for all of DCC employees to understand their product from a safety, regulatory and ethical perspective. This will provide understanding of the importance of implementing ethical standards when working in humans and animals for any future research activities, while following the specific guidelines and acting as a responsible corporate citizen. The drawbacks to this approach could involve a logistical and financial burden on the company as it may require an increase in headcount for hiring experts and for the development of the code of conduct